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Abstract: The increasing prevalence of high myopia has been noted. We investigated the epidemiological
characteristics and the related factors of high myopia in a Japanese adult population. Japan Public
Health Center-Based Prospective Study for the Next Generation (JPHC-NEXT) Eye Study was
performed in Chikusei-city, a rural area in mid-east Japan, between 2013 and 2015. A cross-sectional
observational analysis was conducted to investigate prevalence and related factors of high myopia.
A total of 6101 participants aged ≥40 years without a history of ocular surgeries was included. High
myopia was defined as a spherical equivalent refraction of ≤−6.00 diopters according to the American
Academy of Ophthalmology. Potential high myopia-related factors included intraocular pressure
(IOP), corneal structure, corneal endothelial cell density, age, height, body mass index, heart rate,
blood pressure, biochemical profile, and current history of systemic and ocular disorders. The odds
ratios of high myopia were estimated using the logistic regression models adjusted for the associated
factors. The prevalence of high myopia was 3.8% in males and 5.9% in females with a significant
difference. Age was inversely associated, IOP was positively associated, and none of other factors
were associated with high myopia in both sexes. In conclusion, only age and IOP were associated
with high myopia in this community-based sample.
Keywords: high myopia; intraocular pressure; associated factors
1. Introduction
Myopia is one of the most prevalent conditions of the eye. It causes visual impairment in both
children and adults that is usually correctable by optical aids such as glasses and contact lenses.
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High myopia is generally determined as −6.00 diopters (D) or less in refraction and axial lengths of
26.5 mm and more by the American Academy of Ophthalmology [1]. High myopia is associated with
progressive and excessive elongation of the eyeball, which results in various funduscopic changes in
the posterior fundus, and increases the risk of pathologic myopia, which may cause irreversible vision
loss such as glaucoma, retinal detachment, and macular degeneration [2]. High myopia is a major
cause of blindness in many countries [3], and the prevalence of myopia and high myopia is expected to
increase globally from 2000 to 2050 [4]. Thus, it is important to manage myopia progression and to
prevent myopia-related ocular complications and vision loss the approximately 1 billion people with
high myopia [4].
Over the past few decades, some studies have provided information on the prevalence and risk
factors for myopia, including genetic predisposition and environmental factors such as extended near
work, less exercise, and luck of outdoor activities [5–7]. However, the etiology of myopia remains
unclear. The length of indoor or outdoor activities [8–10], ethnicity [11], vitamins [12], diabetes [13],
reading habits [14], body stature, lifestyles, and light environment [15–17] were suggested as associated
factors for the progression of myopia.
Human lifestyles are rapidly changing. The factors that may affect the progression of myopia
are essential to understanding and to finding countermeasures for myopia. Community-based
population-based research is a reliable way to elucidate the associated factors. In order to elicit
the high-myopia-associated factors, it was thought to be important to eliminate biases and prejudices
as much as possible. We established this study to screen all the possible factors which were available
in the collected data and personal information without manipulation. In addition, this study targeted
adult population as subjects. Pathological myopia, which is usually preceded by high myopia and seen
mostly in adults, is theoretically thought to be originated from myopia in children. To know possible
associated factors for high myopia in adults is considered to be a crucial key to render solutions to
diminish the number of future high or pathological myopia in children.
We conducted the Japan Public Health Center-Based Prospective Study for the Next Generation
(JPHC-NEXT) Eye Study, an ancillary study of the JPHC-NEXT, to examine the prevalence of refractive
status of the participants and factors associated with high myopia in Chikusei, a rural city in mid-east
Japan. To our knowledge, this is the first large, community-based study to determine the factors
associated with high myopia.
2. Materials and Methods
2.1. Ethics Approval and Consent to Participate
This study followed the tenets of the World Medical Association’s Declaration of Helsinki.
The study protocol was approved by the Institutional Review Boards of Keio University, Osaka
University, the University of Tsukuba, and the National Cancer Center. Written informed consent was
obtained from all the participants.
2.2. Study Design and Participants
JPHC-NEXT Eye Study was performed in two regions: Saku-city and Chikusei-city. The subjects
of this study are participants of annual checkups who are aged 40 years or more in Chikusei-city, and
a total of 7098 subject who had taken ocular examination between 2013 and 2015 were included in
this study. Out of them, 997 participants who had undergone ocular surgeries were excluded because
their refraction may have changed after the procedures. In the end, 6101 participants aged from 40 to
93 years (86.0%) were included in this analysis (Figure 1).
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Figure 1. Study flow chart of this study. The number of participants who were 40 years old and over 
was 7098. Of them, 5987 participants were defined as the subjects after excluding 997 participants 
who had a history of ocular surgery and 114 participants who did not have refractive indices of their 
right eye. 
2.3. Screening Examination 
The screening included ophthalmic examinations (refraction, intraocular pressure, central 
corneal thickness, and corneal endothelium density); measurement of height (HT); weight (WT); 
blood pressure; and serum laboratory data including glutamic oxaloacetic transaminase (GOT), 
glutamic pyruvic transaminase (GPT), gamma-glutamyl transpeptidase (GGTP), total cholesterol (T 
cholesterol), fasting triglyceride (triglycerides), high density lipoprotein (HDL cholesterol), low 
density lipoprotein (LDL cholesterol), fasting blood glucose (glucose), hemoglobin A1c (HbA1c), and 
creatinine; and a history of systemic and ocular disorders. Serum T cholesterol, triglycerides, HDL 
cholesterol, LDL cholesterol, HbA1c, GGTP, and creatinine were measured by visible absorption 
spectrometry. Serum glucose, GOT, and GPT were measured using ultraviolet absorption 
spectrometry. Blood pressure was measured two times, and the second reading was adopted. Height 
and body weight were measured with AD-6350 (A&D Company Ltd., Tokyo, Japan). For blood 
pressure, TN2657P, TM 2657P, TM 2655P, and UM-102 (A&D Company Ltd., Tokyo, Japan) were 
used; for biochemical examinations, BM8060G (NDK Inc., Sagamihara, Japan), LUMIPULSE® G1200 
(FUJIREBIO Inc., Tokyo, Japan) and AIA2000 (Tosoh Corp., Tokyo, Japan) were used; and for blood 
glucose tests, BM9130 (NDK Inc., Sagamihara, Japan) was used. Refractive status and intraocular 
pressure (IOP) were measured using an auto refractometer (Tonoref II, Nidek, Gamagori, Japan). 
Central corneal thickness and corneal endothelium density were measured by using a specular-type 
pachymeter (Specular microscope XIII, Konan, Nishinomiya, Japan). 
2.4. Information on Past Medical History 
Information on histories of hypertension, diabetes, and dyslipidemia was collected through face-
to-face interviews at the baseline survey. Likewise, inquiry about smoking history and alcohol history 
as well as histories of ocular disease and its surgery were also performed. 
2.5. Definitive Examination 
The spherical equivalent refraction (SEq) was calculated from the refraction using the following 
formula: the full spherical power plus half of the cylindrical power. Initially, the mean values of the 
SEq of the right eyes and the left eyes were compared in the entire population of the current study. 
Figure 1. Study flow chart of this study. r f articipants who w re 40 years old and over
was 7098. Of them, 5987 participants ere defined as the subjects after excluding 997 participants
who had a history of ocular surgery and 114 participants who did not have refractive indices of their
right eye.
2.3. Screeni g Examination
The screening included ophthalmic examinations (refraction, intraocular pressure, central corneal
thickness, and corneal endothelium density); easurement of height (HT); weight (WT); blood pressure;
and serum laboratory data including glutamic oxaloacetic transaminase (GOT), glutamic pyruvic
transaminase (GPT), gamma-glutamyl transpeptidase (GGTP), total cholesterol (T cholesterol), fasting
triglyceride (triglycerides), high density lipoprotein (HDL cholesterol), low density lipoprotein (LDL
cholesterol), fasting blood glucose (glucose), hemoglobin A1c (HbA1c), and creatinine; and a history of
systemic and ocular disorders. Serum T cholesterol, triglycerides, HDL cholesterol, LDL cholesterol,
HbA1c, GGTP, and creatinine were measured by visible absorption spectrometry. Serum glucose, GOT,
and GPT were measured using ultraviolet absorption spectrometry. Blood pressure was measured two
times, and the second reading was adopted. Height and body weight were measured with AD-6350
(A&D Company Ltd., Tokyo, Japan). For blood pressure, TN2657P, TM 2657P, TM 2655P, and UM-102
(A&D Company Ltd., Tokyo, Japan) were used; for biochemical examinations, B 8060G (NDK Inc.,
Sagamihara, Japan), LUMIPULSE® G1200 (FUJIREBIO Inc., , J ) and AIA2000 (T soh Corp.,
Tokyo, Japan) were used; and for blood glucose tests, BM9130 (NDK Inc., Sagamihara, Japan) was used.
Refractive status and intraoc lar pressure (IOP) we e measured using an auto refractometer (Tonoref II,
Nidek, Gamagori, Japa ). Central corn al thickness and corn al endoth lium de sity were measured
by using a specular-type pachymeter (Specular microscope XIII, Konan, Nishinomiya, Japan).
2.4. Information on Past Medical History
Information on histories of hypertension, diabetes, and dyslipidemia was collected through
face-to-face interviews at the baseline survey. Likewise, inquiry about smoking history and alcohol
history as well as histories of ocular disease and its surgery were also performed.
2.5. Definitive Examination
The spherical equivalent refraction (SEq) was calculated from the refraction using the following
formula: the full spherical power plus half of the cylindrical power. Initially, the mean values of the
SEq of the right eyes and the left eyes were compared in the entire population of the current study.
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There was no significant difference in the median SEq between the right eyes and the left eyes (−0.13
vs −0.00 (D), p = 0.10). Thus, we used the SEq of the right eyes to evaluate the refractive status in
this study. A high myopia was defined as SEq of −6.00 D or less based on the American Academy of
Ophthalmology criteria [1].
2.6. Statistical Analysis
The prevalence of high myopia was calculated in total participants, in men and women, and in the
groups classified by age. Chi-square test for the prevalence of high/non-high myopia in each sex was
performed. When it demonstrated significant difference, comparison of variables between high myopia
and non-high myopia groups in each sex was performed; continuous variables showing parametric
distribution were analyzed with Student’s t-test, and variables showing nonparametric distribution
were analyzed with Mann–Whitney U test. Logistic regression was used to estimate odds ratios (ORs)
and 95% confidence intervals (CIs), adjusting for age and for likely possible risk factors associated
with high myopia. Multivariate logistic analyses were performed using variables showing significant
difference in each sex as adjustment factors, since variables showing significance (p < 0.05) are different
from each other by comparison between non-high myopia and high myopia groups in both sexes.
Units are different among variables, and therefore, they are categorized by quartiles. A p value of less
than 0.05 was considered statistically significant. Statistical analyses were performed with the SPSS
version 23.0 for Windows (IBM, Armonk, NY, USA).
3. Results
3.1. Participants
Among a total of 5987 subjects, the numbers of men and women were 2427 and 3557, respectively.
The prevalence of high myopia in the current study was 5.0%, 3.8% in men and 5.9% in women. High
myopia was more prevalent among women than men (p < 0.001). According to the age distribution,
the prevalence of high myopia in the 40s, 50s, 60s, 70s, 80s, and 90s was 10.6%, 8.8%, 3.5%, 2.0%, 1.2%,
and 0.0%, respectively (Figure 2). The median SEq of the right eyes in total was −0.13 D, ranging
from −23.13 D to +10.25 D, with the 1st quartile at −1.38 and the 3rd quartile at +0.88 D. In the men,
the median SEq was −0.13 D, ranging from −18.88 D to +10.25 D, with the 1st quartile at −1.25 and the
3rd quartile at +0.88 D. In the women, the median SEq was −0.13 D, ranging from −23.13 D to +6.88 D,
with the 1st quartile at −1.63 and the 3rd quartile at +0.88 D. The median SEq of the right eye was not
significantly different between genders (p = 0.52).
3.2. Associations Between Systemic Factors and High Myopia
We evaluated the associations between systemic factors and high myopia (Table 1). The mean age
for the high myopia group was significantly lower than the non-high myopia group (55.7 ± 10.5 vs
62.8 ± 10.3 years, p < 0.001). The peak of the high myopia prevalence by age was from 40 to 49 years
(6.2% among the men and 13.0% among the women). The mean height for the high myopia group
was significantly higher than others (158.8 ± 8.0 vs 157.5 ± 8.7 cm, p = 0.009). A similar difference was
also found in the age and heights of men and women, respectively (Table 1). No significant difference
between the high myopia group and non-high myopia group was observed in weight, waist, and
diastolic blood pressure. Among the laboratory data, T cholesterol, triglycerides, and LDL cholesterol
were significantly different between the two groups in men. Glucose and HbA1c were significantly
different between the two groups in the women. Regarding the relationship between alcohol intake
and high myopia, ORs for high myopia and alcohol intake history were 1.166 (95%CI 0.371–3.662) in
the men and 0.900 (95%CI 0.467–1.732) in the women. ORs for high myopia and tobacco use history
were 0.598 (95%CI 0.340–1.051) in the men and 0.967 (95%CI 0.593–1.577) in the women (Table S1).
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Table 1. The association between systemic and ocular features and high myopia.
Mean ± SD
Variables Non-High Myopia High Myopia p Value
All (n = 5984)
Ag 62.8 ± 10.3 55.7 ± 10.5 <0.001
HT 157.6 ± 8.7 158.8 ± 8.0 0.009
BMI 23.2 ± 3.3 22.8 ± 4.1 0.093
HR 63.8 ± 13.5 64.3 ± 14.8 0.669
SBP 124.8 ± 17.6 121.0 ± 18.9 0.001
DBP 74.4 ± 11.6 73.9 ± 13.3 0.504
GOT 24.1 ± 37.9 22.1 ± 8.4 0.422
GPT 21.3 ± 31.7 20.6 ± 12.9 0.737
GGTP 34.0 ± 43.9 30.0 ± 24.3 0.022
T CHOL 209.4 ± 35.6 213.0 ± 35.0 0.082
TG 96.0 † 84.0 † 0.595 ††
HDL CHOL 63.1 ± 15.7 65.3 ± 15.4 0.034
LDL CHOL 126.7 ± 31.7 130.8 ± 31.7 0.052
GLU 96.0† 93.0 † <0.001 ††
HbA1c 5.8 ± 0.7 5.7 ± 0.5 0.004
Creatinine 0.7 ± 0.3 0.7 ± 0.1 0.014
IOP 13.3 † 14.3 † <0.001 ††
Corneal radius 7.6 † 7.6 † 0.070 ††
Central corneal thickness 553.0 † 557.0 † 0.102 ††
Corneal endothelial cell number 2747.0 † 2740.0† 0.174 ††
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Table 1. Cont.
Mean ± SD
Variables Non-High Myopia High Myopia p Value
Men (n = 2427)
Age 64.2 ± 10.4 58.7 ± 11.2 <0.001
HT 164.8 ± 6.5 166.7 ± 6.4 0.007
BMI 23.8 ± 3.1 24.3 ± 4.2 0.169
HR 62.6 ± 13.7 63.4 ± 14.5 0.666
SBP 128.6 ± 17.1 129.4 ± 17.9 0.684
DBP 76.8 ± 11.6 78.5 ± 12.4 0.176
GOT 26.4 ± 58.1 23.6 ± 8.0 0.677
GPT 24.7 ± 47.3 24.9 ± 12.1 0.972
GGTP 46.3 ± 58.7 40.0 ± 24.2 0.374
T CHOL 119.3 ± 33.7 209.3 ± 31.3 0.003
TG 105.0 † 117.0 † 0.023 ††
HDL CHOL 57.0 ± 14.5 56.4 ± 13.7 0.733
LDL CHOL 121.0 ± 30.7 129.7 ± 29.9 0.020
GLU 99.0 † 99.0 † 0.597 ††
HbA1c 5.8 ± 0.8 5.7 ± 0.5 0.215
Creatinine 0.9 ± 0.3 0.9 ± 0.1 0.733
IOP 13.3 † 15.0 † <0.001 ††
Corneal radius 7.7 † 7.7 † 0.198 ††
Central corneal thickness 556.0 † 565.0 † 0.391 ††
Corneal endothelial cell number 2793.0 † 2789.5 † 0.538 ††
Women (n = 3557)
Age 61.8 ± 10.2 54.4 ± 9.9 <0.001
HT 152.5 ± 6.2 155.4 ± 5.9 0.001
BMI 22.8 ± 3.5 22.2 ± 3.9 0.012
HR 64.6 ± 13.4 64.6 ± 15.0 0.964
SBP 122.1 ± 17.5 117.4 ± 18.2 <0.001
DBP 72.7 ± 11.3 71.9 ± 13.2 0.358
GOT 22.5 ± 9.2 21.5 ± 8.5 0.168
GPT 19.0 ± 11.7 18.7 ± 12.9 0.815
GGTP 25.4 ± 26.2 25.6 ± 23.2 0.920
T CHOL 216.4 ± 35.1 214.6 ± 36.4 0.461
TG 90.0 † 83.0 † 0.076 ††
HDL CHOL 67.3 ± 15.1 69.2 ± 14.4 0.117
LDL CHOL 130.6 ± 31.8 131.3 ± 32.5 0.783
GLU 95.0 † 91.0 † <0.001 ††
HbA1c 5.8 ± 0.6 5.6 ± 0.5 0.011
Creatinine 0.6 ± 0.1 0.6 ± 0.1 0.235
IOP 13.7 † 14.0 † 0.038 ††
Corneal radius 7.6 † 7.6 † 0.327 ††
Central corneal thickness 551.0 † 553.5 † 0.159 ††
Corneal endothelial cell number 2740.0 † 2725.0 † 0.159 ††
Non-high myopia: SEq > −6D, High myopia: SEq ≤ −6D. †: Median. ††: Mann–Whitney U test. HT = height, BMI =
body mass index, HR = heart rate, SBP = systolic blood pressure, DBP = diastolic blood pressure, GOT = glutamic-
oxaloacetic transaminase, GPT = glutamate pyruvate transaminase, GGTP = gamma-glutamyl transpeptidase,
T CHOL = total cholesterol, TG = triglyceride, HDL CHOL= high-density lipoprotein cholesterol, LDL CHOL =
low-density lipoprotein cholesterol, GLU = glucose, HbA1c = Hemoglobin A1c, IOP = intraocular pressure.
3.3. Associated Between Ocular Features and High Myopia
Associations between ocular features and high myopia were also evaluated (Table 1). The median
IOP was significantly higher for the high myopia group than the others (14.30 vs 13.30 mmHg, p < 0.001).
Similar differences were found in the median IOPs of the men or women, respectively. A significant
difference was also observed in the median corneal radius between the high myopia group and the
others (7.62 vs. 7.64 mm, p = 0.024). However, no significant difference was found in the median
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corneal radii of the men and women, respectively. There was no significant difference in central corneal
thickness and corneal endothelial cell number between the two groups.
3.4. IOP and Age Associated with High Myopia
A multivariable logistic regression analysis was performed to identify the factors associated with
high myopia (Table 2 and Table S2). The ORs adjusted for multivariable factors were significant for
age and IOP in the men and the women. In men, the values were as follows: the ORs adjusted with
other factors for high myopia in each age group were 40–58 years (OR 1), 59–65years (OR 0.44, 95%CI
0.22–0.89), 66–70 years (OR 0.43, 95%CI 0.20–0.93), and no younger than 71 years (OR 0.48, 95%CI
0.22–1.06, p for trend 0.049). The ORs adjusted with other factors for high myopia in the groups of IOP
were ≤11.2 mmHg (OR 1), 11.3–13.2 mmHg (OR 3.34, 95%CI 0.93–12.00), 13.3–15.2 mmHg (OR 5.18,
95%CI 1.49–18.04), and ≥15.3 mmHg (OR 7.73, 95%CI 2.24–26.77), respectively (p for trend <0.001).
Table 2. Multivariate logistic regression analysis to identify factors associated with high myopia.
OR 95% CI p Value
Men
Age ≤58 1
59–65 0.44 (0.221–0.886)
66–70 0.43 (0.197–0.930)
≥71 0.48 (0.219–1.059)
p for trend 0.049
HT ≤160 1
161–164 0.95 (0.388–2.318)
165–168 1.42 (0.620–3.271)
≥169 1.65 (0.722–3.784)
p for trend 0.131
BMI ≤21.6 1
21.7–23.5 1.41 (0.660–3.020)
23.6–25.6 0.96 (0.423–2.188)
≥25.7 1.07 (0.479–2.368)
p for trend 0.836
SBP ≤116 1
117–127 0.61 (0.272–1.364)
128–138 0.98 (0.481–1.978)
≥139 0.83 (0.396–1.741)
p for trend 0.912
TG ≤73 1
74–105 2.93 (1.126–7.616)
106–149 3.10 (1.183–8.103)
≥150 2.79 (1.018–7.619)
p for trend 0.117
HDL CHOL ≤46 1
47–54 0.78 (0.374–1.625)
55–64 0.99 (0.473–2.065)
≥65 1.14 (0.529–2.442)
p for trend 0.682
LDL CHOL ≤100 1
101–119 2.07 (0.909–4.729)
120–139 1.44 (0.615–3.371)
≥140 1.72 (0.758–3.892)
p for trend 0.348
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Table 2. Cont.
OR 95% CI p Value
HbA1c ≤5.3 1
5.4–5.5 0.84 (0.390–1.797)
5.6–5.9 0.75 (0.355–1.579)
≥6.0 0.83 (0.377–1.811)
p for trend 0.453
IOP ≤11.2 1
11.3–13.2 3.34 (0.927–12.002)
13.3–15.2 5.18 (1.487–18.037)
≥15.3 7.73 (2.235–26.768)
p for trend <0.001
Central corneal thickness ≤531 1
532–556 0.93 (0.421–2.053)
557–583 1.05 (0.483–2.269)
≥584 1.01 (0.471–2.180)
p for trend 0.847
Women
Age ≤54 1
55–62 0.57 (0.358–0.904)
63–68 0.35 (0.208–0.586)
≥69 0.21 (0.106–0.405)
p for trend <0.001
HT ≤147 1
148–152 0.88 (0.486–1.594)
153–156 1.03 (0.571–1.872)
≥157 1.35 (0.752–2.424)
p for trend 0.195
BMI ≤20.3 1
20.4–22.3 0.76 (0.481–1.205)
22.4–24.6 0.58 (0.344–0.977)
≥24.7 0.68 (0.399–1.156)
p for trend 0.120
SBP ≤108 1
109–120 0.74 (0.458–1.191)
121–132 0.87 (0.520–1.457)
≥133 1.02 (0.605–1.729)
p for trend 0.698
TG ≤66 1
67–89 0.85 (0.530–1.352)
90–124 0.77 (0.455–1.288)
≥125 0.94 (0.547–1.619)
p for trend 0.624
HDL CHOL ≤56 1
57–65 1.37 (0.810–2.298)
66–75 1.25 (0.735–2.116)
≥76 1.02 (0.583–1.785)
p for trend 0.801
LDL CHOL ≤107 1
108–127 1.07 (0.629–1.830)
128–149 2.07 (1.273–3.352)
≥150 1.27 (0.744–2.149)
p for trend 0.121
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Table 2. Cont.
OR 95% CI p Value
HbA1c ≤5.4 1
5.5–5.6 1.29 (0.833–1.993)
5.7–5.8 0.85 (0.493–1.463)
≥5.9 1.03 (0.618–1.731)
p for trend 0.738
IOP ≤11.6 1
11.7–13.6 2.23 (1.226–4.052)
13.7–15.6 2.25 (1.213–4.157)
≥15.7 2.33 (1.239–4.367)
p for trend 0.023
Central corneal thickness ≤524 1
525–550 0.83 (0.508–1.361)
551–574 0.70 (0.423–1.164)
≥575 0.92 (0.561–1.523)
p for trend 0.730
N on-high myopia: SEq > −6D, high myopia: SEq ≤ −6D, OR: Adjusted by age, HT, BMI, SBP, TG, HDL CHOL,
LDL CHOL, HbA1c, IOP, and central corneal thickness. HT = height, BMI = body mass index, SBP = systolic
blood pressure, TG = triglyceride, HDL CHOL = high-density lipoprotein cholesterol, LDL CHOL= low-density
lipoprotein cholesterol, HbA1c = Hemoglobin A1c, IOP = intraocular pressure.
In women, the values were as follows: the ORs adjusted with other factors for high myopia in each
age group were 40–54 years (OR 1), 55–62 years (OR 0.57, 95%CI 0.36–0.90), 63–68 years (OR 0.35, 95%CI
0.21–0.59), and no younger than 69 years (OR 0.21, 95%CI 0.11–0.41) (p for trend <0.001). The ORs
adjusted with other factors in each IOP group were ≤11.6 mmHg (OR 1), 11.7–13.6 mmHg (OR 2.23,
95%CI 1.23–4.05), 13.7–15.6 mmHg (OR 2.25, 95%CI 1.21–4.16), and ≥15.7 mmHg (OR 2.33, 95%CI
1.24–4.37), respectively (p for trend 0.023). In summary, as the age increases, the OR decreases and,
as the IOP increases, the OR increases in both men and women.
4. Discussion
This community-based study showed the prevalence of high myopia and associated factors
including physical, ocular, and demographic factors among adult Japanese for the first time. The factors
associated with myopia were widely investigated as we analyzed biochemistry tests, blood pressure,
height, body weight, habit of smoking, alcohol intake, past medical history, and present diseases.
In this current study, we found that high myopia is more prevalent in women and younger age and
that it has higher IOP.
High myopia affects approximately 1–4% of adults aged ≥40 years, and its prevalence was higher
in some studies of East Asian adults and adolescents [18–25]. Our findings showed that the prevalence
of high myopia was 5.0%, which was no less than the generally affected rates, although Chikusei-city
is in a rural area where its prevalence has usually been lower compared to urban areas [25]. In our
study, the high myopia rate in the older population was relatively low and the younger generation had
a higher prevalence of high myopia, which may reflect cohort effects. Although the reason for this
cohort effects is unknown, the prevalence of high myopia could be expected to increase in the future.
Some previous studies reported the relationship of height [26–28] and BMI [29–31] with myopia;
however, we did not find such association. A possible reason for this discrepancy is confounding;
the previous reports did not adjust for age and any other confounding factors. In fact, BMI and height
were shown to be associated with high myopia in unadjusted models and adjustment for age resulted
in the elimination of this significance in our study, presumably because age is a strong predisposing
factor for BMI and height reflecting cohort effects.
As for the other laboratory factors, there was no significant difference. A few studies suggested
that hyperglycemia and hyperlipidemia led to myopic shift, whereas other studies revealed that the
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refractive shift was more likely hyperopic with hypoglycemia [32–35]. Further analysis is needed to
elucidate the influence of metabolic shift.
In terms of alcohol intake and smoking history, both factors did not show any associations with
high myopia according to our results. Also, liver functions, represented by GOT, GPT, and GGTP,
did not show any relationship to high myopia. Previous reports also found that there were no significant
trends observed between smoking and refractive errors [36].
The percentages of high myopia in men and women were 3.8% and 5.9%, respectively, indicating
significant gender difference. It has been reported that female sex had a predisposition of high
myopia [37]. Likewise, female sex was proven to have high risk for myopic complications usually
caused by high myopia [38]. Hyman et al. reported that female sex is independently associated with
faster myopic progression [39], although there have been no reports describing causal relationship
between gender and high myopia.
The mean IOP linearly increased parallel to the myopic progression. It has been reported that IOP
was associated with central corneal thickness, age, and blood pressure [40,41]. Even after adjustment
for these factors, we still found that high IOP was significantly associated with high myopia, while
there are conflicting evidences regarding relationship of high myopia and IOP [42–44].
Although this cross-sectional study is to investigate the risk factors for high myopia through a
large-scale cross-sectional study, a few studies with relatively small number of subjects were undertaken.
Mo et al. [37] concluded in their study performed in a rural area in China with 167 participants that
females may be a risk factor for myopia and that advanced age is a factor for decreased visual acuity.
As for the results obtained from this large-scale study showing that being young, being a woman,
and having high IOP are the risk factors for high myopia, we investigated previous articles regarding
these factors. Matamoros et al. [45] reported in their study that prevalence of high myopia was higher
in 20- to 39-year-old subjects as well as among women than men, which are consistent with our
results. Otherwise, being a woman has well been reported to be a risk factor for myopia in some other
studies [46]. Attebo et al. [46] also confirmed an age-related increase in hyperopia associated with an
age-related decrease in myopia; however, a distinct association between high myopia and age has
not been elucidated. Concerning relationships between high myopia and glaucoma, Chen et al. [47]
reported high myopia as a risk factor in primary open angle glaucoma (POAG) and elevated intraocular
pressure as a well-known major risk factor for POAG. Nevertheless, there have been no reports
describing direct association between high IOP and high myopia.
There are some limitations in this study. First of all, the study design is not completely reasonable
because the data used for the analysis are practically limited. Although the JPHC-NEXT study is large
scale in terms of the participant number, it is basically a universal data collection based on regular
checkups performed in a rural area. Therefore, this is not conducted specifically for ophthalmological
analysis. The study would have been more informative if it contained questionnaires or interviews
concerning the time for near-work and indoor/outdoor activities as well as academic levels and heredity
of myopia. In addition, another limitation of this study is the lack of ophthalmological analysis
including the measurement of axial length and lens corrections, which are crucial to determine the
participants’ classification of non-/high myopia. This study should be completed with these detailed
data to make the conclusions more reliable; however, it could be done only beyond the limitation of
this cross-sectional study. Owing to the large-scale study, instead, we were able to effectively assess a
large number of basically healthy participants altogether and to draw these critical results. The factors
associated with high myopia were undetermined. This study did not suggest that height, BMI, blood
glucose, hypocholesteremia, liver dysfunction, kidney dysfunction, smoking, and alcohol intake were
associated with high myopia, whereas women, young age, and high IOP were found to be related
to high myopia. Meanwhile, high IOP and young age were found to be risk factors for high myopia,
which may indicate the path for future studies concerning myopia control.
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5. Conclusions
In conclusion, this epidemiological study performed in a Japanese rural area revealed significant
results: being a women, being young, and having high IOP were factors associated with high myopia,
while height, BMI, cholesterol level, glucose level, and other considered possible risk factors for high
myopia in previous studies were not associated with prevalence of myopia.
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/8/11/1788/s1,
Table S1: The association between alcohol, tobacco and high myopia. Table S2: Logistic regression analysis to
identify factors associated with high myopia.
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